Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bausch Health Companies Inc BHC


Primary Symbol: T.BHC

Healthcare
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

Recent & Breaking News (TSX:BHC)

Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations

Canada NewsWire February 12, 2020

Bausch Health Announces Participation In Upcoming Investor Conferences

Canada NewsWire February 4, 2020

Bausch + Lomb And Prevent Blindness Join Together To Raise Awareness And Provide Educational Resources For February's Age-Related Macular Degeneration Awareness Month

Canada NewsWire February 3, 2020

Ortho Dermatologics Opens 2020 Aspire Higher Scholarship Program

Canada NewsWire February 3, 2020

Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology

PR Newswire January 28, 2020

Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2019 Financial Results on February 19

PR Newswire January 16, 2020

Bausch Health Publishes Company Update for the 38th Annual J.P. Morgan Healthcare Conference

PR Newswire January 13, 2020

Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Data On ARAZLO(TM) (tazarotene) Lotion, 0.045% In The Journal Of Drugs In Dermatology (JDD)

Canada NewsWire January 13, 2020

Bausch + Lomb Launches Expanded Parameters for Biotrue® ONEday for Astigmatism Daily Disposable Contact Lenses

Canada NewsWire January 6, 2020

Bausch Health To Participate At The 38th Annual J.P. Morgan Healthcare Conference

PR Newswire January 6, 2020

Bausch Health Licenses Novaliq's NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction

PR Newswire December 20, 2019

Bausch Health Announces Resolution Of BRYHALI® (Halobetasol Propionate) Lotion, 0.01%, Intellectual Property Litigation With Glenmark

Canada NewsWire December 20, 2019

Bausch + Lomb Announces VYZULTA® (Latanoprostene Bunod Ophthalmic Solution 0.024%) Now Publicly Covered Under the Ontario Public Drug Benefit (ODB) Program

Canada NewsWire December 19, 2019

FDA Approves Ortho Dermatologics' ARAZLOTM (Tazarotene) Lotion, 0.045%, For Acne Vulgaris

Canada NewsWire December 19, 2019

Bausch Health Announces Conditional Redemption Of Existing Senior Notes

Canada NewsWire December 18, 2019

Bausch Health Announces Pricing of Private Offering of Senior Notes

Canada NewsWire December 17, 2019

Bausch + Lomb Initiates Clinical Trial Evaluating New Cohesive Ophthalmic Viscosurgical Device (OVD) For Use In Cataract Surgery

Canada NewsWire December 17, 2019

Bausch Health Announces Launch Of Private Offering Of Senior Notes

Canada NewsWire December 17, 2019

Bausch Health Resolves "Stock Drop" Litigation Initially Filed in October 2015

PR Newswire December 16, 2019

Quarterly S&P/TSX Composite Index Review - December 2019

Canada NewsWire December 13, 2019